Peer Perspectives on mTOR

The science behind mTOR's role as a regulator of many cell processes — and its potential as a therapeutic target — is complex. The medical community's understanding of this science and its clinical implications is constantly evolving. In this section, your peers in the research and clinical fields of oncology share their knowledge and perspectives on targeting mTOR and the value that mTOR inhibition may offer in an oncology therapeutic regimen.

The physician views expressed do not necessarily reflect the views of other physicians.
Research Scientist Perspectives

Answers from researchers who are at the forefront of work that is expanding our knowledge of mTOR's structure and functions in normal cells, the role mTOR plays in cancer, and the role mTOR inhibition may play in cancer treatment.

Dr. Bill SellersmTOR Q&A with William Sellers, MD
Global Head of Oncology
Novartis Institutes for Biomedical Research

E-mail this page
Print this page
Change font sizes